Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine

Brain

Volumn 126, Issue 12, 2003, Pages 2750-2760

  Parry, Allyson M M ^a   Scott, Richard B ^b   Palace, Jacqueline ^b   Smith, Stephen ^a   Matthews, Paul M ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Cerebral plasticity; Cognition; fMRI; Multiple sclerosis; Neurophysiology

Indexed keywords

CHOLINESTERASE INHIBITOR; RIVASTIGMINE;

ADULT; ARTICLE; BASAL GANGLION; BRAIN DEPTH STIMULATION; BRAIN MAPPING; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MODULATION; MULTIPLE SCLEROSIS; NAUSEA; NERVE CELL PLASTICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; TASK PERFORMANCE;

ADULT; CARBAMATES; CHOLINESTERASE INHIBITORS; COGNITION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEURONAL PLASTICITY; NEUROPSYCHOLOGICAL TESTS; PHENYLCARBAMATES; PREFRONTAL CORTEX;

EID: 0344443214     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg284     Document Type: Article

References (68)

1. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of brain activation in people at risk for Alzheimer's disease. New Engl J Med 2000; 343: 450-6.
2. Brass M, Zysset S, von Cramon DY. The inhibition of imitative response tendencies. Neuroimage 2001; 14: 1416-23.
3. Bush G, Whalen PJ, Rosen BR, Jenike MA, McInerney SC, Rauch SL. The counting Stroop: an interference task specialized for functional neuroimaging-validation study with functional MRI. Hum Brain Mapp 1998; 6: 270-82.
4. Butefisch CM, Davis BC, Wise SP, Sawaki L, Kopylev L, Classen J, et al. Mechanisms of use-dependent plasticity in the human motor cortex. Proc Natl Acad Sci USA 2000; 97: 3661-5.
5. Carter CS, Braver TS, Batch DM, Botvinick MM, Noll D, Cohen JD. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 1998; 280: 747-9.
6. Chaudhuri A, Behan PO. Fatigue and basal ganglia. J Neurol Sci 2000; 179: 34-42.
7. Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002; 52: 650-3.
8. Crawford JR, Moore JW, Cameron IM. Verbal fluency: a NART-based equation for the estimation of premorbid performance. Br J Clin Psychol 1992; 31: 327-9.
9. Dupont S, Van de Moortele PF, Samson S, Hasboun D, Poline JB, Adam C, et al. Episodic memory in left temporal lobe epilepsy: a functional MRI study. Brain 2000; 123: 1722-32.
10. Duvernoy HM. The human brain stem and cerebellum. Wien: Springer-Verlag; 1995.
11. Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000; 47: 391-5.
12. Everitt BJ, Robbins TW. Central cholinergic systems and cognition. Annu Rev Psychol 1997; 48: 649-84.
13. Feinstein A, Kartsounis LD, Miller DH, Youl BD, Ron MA. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study. J Neurol Neurosurg Psychiatry 1992; 55: 869-76.
14. Forman SD, Cohen JD, Fitzgerald M, Eddy WF, Mintun MA, Noll DC. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn Reson Med 1995; 33: 636-47.
15. Freo U, Pizzolato G, Dam M, Ori C, Battistin L. A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials. J Neural Transm 2002; 109: 857-70.
16. Friston K, Worsley KJ, Frackowiak RS, Mazziotta JC, Evans AC. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp 1994; 1: 210-20.
17. Furey ML, Pietrini P, Haxby JV, Alexander GE, Lee HC, VanMeter J, et al. Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. Proc Natl Acad Sci USA 1997; 94: 6512-6.
18. Gehring WJ, Knight RT. Prefrontal-cingulate interactions in action monitoring. Nat Neurosci 2000; 3: 516-20.
19. Greene YM, Tariot PN, Wishart H, Cox C, Holt CJ, Schwid S, et al. A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments. J Clin Psychopharmacol 2000; 20: 350-6.
20. Himmelheber AM, Sarter M, Bruno JP. The effects of manipulations of attentional demand on cortical acetylcholine release. Brain Res Cogn Brain Res 2001; 12: 353-70.
21. Jacobs KM, Donoghue JP. Reshaping the cortical motor map by unmasking latent intracortical connections. Science 1991; 251: 944-7.
22. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001; 5: 143-56.
23. Kimberg DY, Aguirre GK, Lease J, D'Esposito M. Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI. Hum Brain Mapp 2001; 12: 246-57.
24. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
25. Lauritzen M. Relationship of spikes, synaptic activity, and local changes of cerebral blood flow. J Cereb Blood Flow Metab 2001; 21: 1367-83.
26. Lee M, Reddy H, Johansen-Berg H, Pendlebury S, Jenkinson M, Smith S, et al. The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. Ann Neurol 2000; 47: 606-13.
27. Leung HC, Skudlarski P, Gatenby JC, Peterson BS, Gore JC. An event-related functional MRI study of the stroop color word interference task. Cereb Cortex 2000; 10: 552-60.
28. Levy LM, Ziemann U, Chen R, Cohen LG. Rapid modulation of GABA in sensorimotor cortex induced by acute deafferentation. Ann Neurol 2002; 52: 755-61.
29. Li Y, Jiang N, Powers C, Chopp M. Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke 1998; 29: 1972-80.
30. Logothetis NK. The neural basis of the blood-oxygen-level-dependent functional magnetic resonance imaging signal. Philos Trans R Soc Lond B Biol Sci 2002; 357: 1003-37.
31. Majors JE, Meyers KR. Rey Complex Figure Completion. Odessa (FL): Psychological Assessment Resources; 1991.
32. Mattay VS, Tessitore A, Callicott JH, Bertolino A, Goldberg TE, Chase TE, et al. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 2002; 51: 156-64.
33. McGaughy J, Everitt BJ, Robbins TW, Sarter M. The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins. Behav Brain Res 2000; 115: 251-63.
34. Mesulam MM, Volicer L, Marquis JK, Mufson EJ, Green RC. Systematic regional differences in the cholinergic innervation of the primate cerebral cortex: distribution of enzyme activities and some behavioral implications. Ann Neurol 1986; 19: 144-51.
35. Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998; 121: 3-24.
36. Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001; 24: 167-202.
37. Muir JL, Dunnett SB, Robbins TW, Everitt BJ. Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task. Exp Brain Res 1992; 89: 611-22.
38. Nelson HE. National Adult Reading Test (NART). 2nd ed. Windsor (UK): NFER-Nelson; 1991.
39. Perret E. The left frontal lobe of man and the suppression of habitual responses in verbal categorical behaviour. Neuropsychologia 1974; 12: 323-30.
40. Peterson BS, Skudlarski P, Gatenby JC, Zhang H, Anderson AW, Gore JC. An fMRI study of Stroop word-color interference: evidence for cingulate subregions subserving multiple distributed attentional systems. Biol Psychiatry 1999; 45: 1237-58.
41. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
42. Pujol J, Vendrell P, Deus J, Junque C, Bello J, Marti-Vilalta JL, et al. The effect of medial frontal and posterior parietal demyelinating lesions on stroop interference. Neuroimage 2001; 13: 68-75.
43. Rao SM, Leo GJ, Haughton VM, Aubin-Faubert P, Bernardin L, Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989; 39: 161-6.
44. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41: 685-91.
45. Reddy H, Narayanan S, Arnoutelis R, Jenkinson M, Antel J, Matthews PM, et al. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. Brain 2000; 123: 2314-20.
46. Rombouts SA, Barkhof F, Van Meel CS, Scheltens P. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002; 73: 665-71.
47. Rudick RA, Fisher E, Lee JC, Simon J, Jacobs L. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999; 53: 1698-704.
48. Ruff CC, Woodward TS, Laurens KR, Liddle PF. The role of the anterior cingulate cortex in conflict processing: evidence from reverse stroop interference. Neuroimage 2001; 14: 1150-8.
49. Sanes JN, Suner S, Lando JF, Donoghue JP. Rapid reorganization of adult rat motor cortex somatic representation patterns after motor nerve injury. Proc Natl Acad Sci USA 1988; 85: 2003-7.
50. Sarter M, Bruno JP, Turchi J. Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders. Ann NY Acad Sci 1999; 877: 368-82.
51. Sawaki L, Boroojerdi B, Kaelin-Lang A, Burstein AH, Butefisch CM, Kopylev L, et al. Cholinergic influences on use-dependent plasticity. J Neurophysiol 2002; 87: 166-71.
52. Schlosser R, Hutchinson M, Joseffer S, Rusinek H, Saarimaki A, Stevenson J, et al. Functional magnetic resonance imaging of human brain activity in a verbal fluency task. J Neurol Neurosurg Psychiatry 1998; 64: 492-8.
53. Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, et al. Women at risk for AD show increased parietal activation during a fluency task. Neurology 2002; 58: 1197-202.
54. Smith KJ, McDonald WI. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1649-73.
55. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17: 479-89.
56. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18: 643-61.
57. Stuss DT, Floden D, Alexander MP, Levine B, Katz D. Stroop performance in focal lesion patients: dissociation of processes and frontal lobe lesion location. Neuropsychologia 2001; 39: 771-86.
58. Swirsky-Sacchetti T, Mitchell DR, Seward J, Gonzales C, Lublin F, Knobler R, et al. Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis. Neurology 1992; 42: 1291-5.
59. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Stuttgart: Thieme; 1988.
60. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. New Engl J Med 1998; 338: 278-85.
61. Turchi J, Sarter M. Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats. Brain Res Cogn Brain Res 1997; 6: 147-58.
62. Vendrell P, Junque C, Pujol J, Jurado MA, Molet J, Grafman J. The role of prefrontal regions in the Stroop task. Neuropsychologia 1995; 33: 341-52.
63. Vitkovitch M, Bishop S, Dancey C, Richards A. Stroop interference and negative priming in patients with multiple sclerosis. Neuropsychologia 2002; 40: 1570-6
64. Warrington EK. Recognition Memory Test. Windsor (UK): NFER-Nelson; 1984.
65. Werring DJ, Bullmore ET, Toosy AT, Miller DH, Barker GJ, MacManus DG, et al. Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 2000; 68: 441-9.
66. Woolrich MW, Ripley BD, Brady M, Smith SM. Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage 2001; 14: 1370-86.
67. Worsley KJ, Evans AC, Marrett S, Neelin P. A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab 1992; 12: 900-18.
68. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.